Cargando…
Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280056/ https://www.ncbi.nlm.nih.gov/pubmed/34091527 http://dx.doi.org/10.1097/CM9.0000000000001587 |
_version_ | 1783722570892181504 |
---|---|
author | Xie, Fei Wang, Shu |
author_facet | Xie, Fei Wang, Shu |
author_sort | Xie, Fei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8280056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-82800562021-07-16 Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 Xie, Fei Wang, Shu Chin Med J (Engl) Consensus Statements Lippincott Williams & Wilkins 2021-07-05 2021-06-04 /pmc/articles/PMC8280056/ /pubmed/34091527 http://dx.doi.org/10.1097/CM9.0000000000001587 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Consensus Statements Xie, Fei Wang, Shu Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title | Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title_full | Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title_fullStr | Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title_full_unstemmed | Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title_short | Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 |
title_sort | clinical practice guideline of brca1/2 testing for patients with breast cancer: chinese society of breast surgery (csbrs) practice guideline 2021 |
topic | Consensus Statements |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280056/ https://www.ncbi.nlm.nih.gov/pubmed/34091527 http://dx.doi.org/10.1097/CM9.0000000000001587 |
work_keys_str_mv | AT xiefei clinicalpracticeguidelineofbrca12testingforpatientswithbreastcancerchinesesocietyofbreastsurgerycsbrspracticeguideline2021 AT wangshu clinicalpracticeguidelineofbrca12testingforpatientswithbreastcancerchinesesocietyofbreastsurgerycsbrspracticeguideline2021 |